Publications

Page: 1 2 3 4
  • Impact of Avoiding Loading Dose of Sirolimus on Wound Complication After Kidney Transplant. A Single Center Experience
    Ayran, M., Jabri, M., El-Ghoroury, M., Oh, H., Provenzano, R., Impact of Avoiding Loading Dose of Sirolimus on Wound Complication After Kidney Transplant. A Single Center Experience.  American Transplant Congress, Seattle, WA , 2005.
  • Positional Differences in Blood Pressure (BP) in Women
    Babbar, N., Steigerwalt, S., Positional Differences in Blood Pressure (BP) in Women. American Society of Hypertension 20th Annual Meeting, San Francisco, CA, 2005.
  • Adequacy of Blood Pressure Management in our Hypertensive Type 2 Diabetic Outpatient Population
    Abboud, J., Castillo, V., Steigerwalt, S., Adequacy of Blood Pressure Management in our Hypertensive Type 2 Diabetic Outpatient Population. American Society of Hypertension 20th Annual Meeting, San Francisco, CA, 2005.
  • Do Cognitive Representations of Medication Behaviors Modify the Impact of Interventions for Blood Pressure Reduction in Women?
    Steigerwalt, S., Scisney-Matlock, M., Do Cognitive Representations of Medication Behaviors Modify the Impact of Interventions for Blood Pressure Reduction in Women?  American Society of Hypertension 20th Annual Meeting, San Francisco, CA, 2005.
  • Safety and Efficacy of Steroid Avoidance and Calcineurin Withdrawal in Recipients of Living Unrelated Renal Allograft (LURA).
    El-Ghoroury, M., Nagrecha, N., Safety and Efficacy of Steroid Avoidance and Calcineurin Withdrawal in Recipients of Living Unrelated Renal Allograft (LURA). National Kidney Foundation Spring Clinical Meeting, Washington, D.C., 2005.
  • Steroid Avoidance and Calcineurin Inhibitor (CI) Minimization in Recipients of Cadaveric Donor Renal Allograft (CRA): A Comparative Study
    Nagrecha, N., El-Ghoroury, M., Steroid Avoidance and Calcineurin Inhibitor (CI) Minimization in Recipients of Cadaveric Donor Renal Allograft (CRA): A Comparative Study. National Kidney Foundation Spring Clinical Meeting, Washington, D.C., 2005.
  • Safety and Efficacy of Sirolimus, Low Dose Tacrolimus and Early Steroid Withdrawal in Patients with Cadaveric Renal Allographs: A Comparative Study
    Nagrecha, N., El-Ghoroury, M., Provenzano, R., Safety and Efficacy of Sirolimus, Low Dose Tacrolimus and Early Steroid Withdrawal in Patients with Cadaveric Renal Allographs: A Comparative Study. American Society of Nephrology Meeting, St. Louis, MO, 2004.
  • The Role of Home Blood Pressure Monitoring (HBPM) in the Control of Hypertension in Renal Transplant Recipients
    Awosika, B., Makos, G., Steigerwalt, S., El-Ghoroury, M., Provenzano, R., The Role of Home Blood Pressure Monitoring (HBPM) in the Control of Hypertension in Renal Transplant Recipients. American Society of Transplantation, Boston, MA, 2004.
  • Low Prevalence of Primary Aldosteronism in Hypertensive Diabetics
    Jefic, D., Al-Sabbagh, R., Fadanelli, M., Steigerwalt, S., Low Prevalence of Primary Aldosteronism in Hypertensive Diabetics. American Society of Hypertension 19th Scientific Meeting , New York, NY, May 2004.
  • Extended Dosing of PROCRIT (Epoetin Alfa) Effectively Treats Anemia and Improves Quality of Life in Patients with Diabetes and CKD
    Provenzano, R., Extended Dosing of Procrit (Epoetin Alfa) Effectively Treats Anemia and Improves Quality of Life in Patients with Diabetes and CKD.  National Kidney Foundation Clinical Meetings, Chicago, IL, 2004.
  • Benign Course of Hypocomplementic Mesangiaoproliferative Glomerulo-nephritis
    Nagrecha, N., Saberi, M., Benign Course of Hypocomplementic Mesangiaoproliferative Glomerulo-nephritis.  National Kidney Foundation Clinical Meetings, Chicago, IL, 2004.
  • Cigarette Smoking is a Predictor of Poorer Renal Survival in Diabetic Patients
    Nagrecha, N., Crook, E., Cigarette Smoking is a Predictor of Poorer Renal Survival in Diabetic Patients, National Kidney Foundation Clinical Meetings, Chicago, IL, 2004.
  • The Dinamap Dilemma: Inaccuracy of the Commonly used Dinamap 8100 Compared to Simultaneous Mercury Manometer Measurement in Hospitalized Patients at Different Levels of Blood Pressure
    Parker, S., Steigerwalt, S., The Dinamap Dilemma: Inaccuracy of the Commonly used Dinamap 8100 Compared to Simultaneous Mercury Manometer Measurement in Hospitalized Patients at Different Levels of Blood Pressure.  American Society of Hypertension, New York NY, 2004.
  • Low Prevalence of Primary Aldosteronism in Hypertensive Diabetics
    Jefic, D., Al-Sabbagh, R., Fadanelli, M., Steigerwalt, S., Low Prevalence of Primary Aldosteronism in Hypertensive Diabetics. American Society of Hypertension, New York, NY, 2004.
  • Long Term AV Graft Survival of Polyurethane (Vectra®) Grafts.
    Rankin, S., Provenzano, R., Flynn, L., Long Term AV Graft Survival of Polyurethane (Vectra®) Grafts. American Society of Nephrology, San Diego, CA, 2003.
  • Spironolactone Use Does Not Increase Serum Potassium in End Stage Renal Disease Patients on Hemodialysis.
    Reddy, P., Steigerwalt, S., Brar, B., Provenzano, R., Spironolactone Use Does Not Increase Serum Potassium in End Stage Renal Disease Patients on Hemodialysis.  American Society of Nephrology, San Diego, CA, 2003.
  • Safety and Efficacy of Calcineurin and Steroid Avoidance in Living Donor Renal Allografts
    Reddy, P., Brar, B., El-Ghoroury, M., Provenzano, R., Oh, H., Fasola, C., Safety and Efficacy of Calcineurin and Steroid Avoidance in Living Donor Renal Allografts.  American Society of Nephrology, San Diego, CA, 2003.
  • Adequacy of Inpatient Versus Outpatient Hemodialysis in End Stage Renal Disease Patients: A Comparative Study.
    Brar, B., Tayeb., J., Reddy, P., Goushaw, P., Provenzano, R.,  Adequacy of Inpatient Versus Outpatient Hemodialysis in End Stage Renal Disease Patients: A Comparative Study.  American Society of Nephrology, San Diego, CA, 2003.
  • Prospective, Randomized Evaluation of Extended Epoetin Alfa Dosing for Treatment of Anemia of Chronic Kidney Disease (CKD): PROMPT Interim Analysis
    Provenzano, R., Bhaduri, S., Tang, K.L., Klausner, M., Singh, A.,  Prospective, Randomized Evaluation of Extended Epoetin Alfa Dosing for Treatment of Anemia of Chronic Kidney Disease (CKD): PROMPT Interim Analysis.  American Society of Nephrology, San Diego, CA, 2003.
  • Aldosterone Is Involved in Left Ventricular Hypertrophy in African American Males with End Stage Renal Disease Treated with Hemodialysis
    Steigerwalt, S., Mesiha, N., Zafar, A., Gardin, J., Provenzano, R.,  Aldosterone Is Involved in Left Ventricular Hypertrophy in African American Males with End Stage Renal Disease Treated with Hemodialysis.  American Society of Nephrology, San Diego, CA, 2003.
  • Incidence and Risk Factors of Nocardiosis in Renal Transplant Recipients
    Pasumarthy, A., Rankin, S., El-Ghoroury, M., Johnson, L.B., Provenzano, R.,  Incidence and Risk Factors of Nocardiosis in Renal Transplant Recipients.  American Society of Nephrology, San Diego, CA, 2003.
  • Once-Weekly (QW) Treatment with Epoetin Alfa in Patients with Anemia Due to Chronic Kidney Disease (CKD)
    [Article listing on pubMed.gov]
    Provenzano, R., Morrison, L., Once-Weekly (QW) Treatment with Epoetin Alfa in Patients with Anemia Due to Chronic Kidney Disease (CKD): Preliminary Analysis. J Am Soc Nephrol 2001:12:A1227.
    OBJECTIVE: To describe the characteristics and prevalence of anemia in patients with diabetes and chronic kidney disease (CKD) not receiving dialysis and to evaluate the efficacy and safety of once-weekly (QW) epoetin alfa for the treatment of anemia in these patients.
  • An Analysis of Bone Disease-Related Medication Use Throughout ESRD.
    Johnson, C., McCarthy, J., Tello, A., Provenzano, R., Deane, J. An Analysis of Bone Disease-Related Medication Use Throughout ESRD. National Conference on Dialysis, New Orleans, LA, 2001
  • Captopril renal scintigraphy in renovascular hypertension
    by Quresh T. Khairullah,  Douglas L. Somers,  Recayi Aktay, American Family Physician,  May 1, 1997
  • The Fluid, Electrolyte and Acid-Base Companion
Page: 1 2 3 4